Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clevidipine in Aneurysmal Subarachnoid Hemorrhage
NCT00978822Phase 2Terminated
- Sponsor
- Henry Ford Health
- Start
- Jun 2009
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clevidipine in aneurysmal subarachnoid hemorrhage (SAH), hypertension (HTN), sponsored by Henry Ford Health. Started Jun 2009; status: terminated.
02
Drugs
clevidipine
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)hypertension (HTN)
Beyond the preview
Go deeper on NCT00978822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00978822.